CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
THRIVE Online PAT Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06388304
NCT06388304N/ACompleted

Pilot Study of Positive Affect Training for Endocrine Therapy Medication Adherence

Joanna Arch·interventional·Posted Apr 29, 2024·Updated Jan 21, 2026

In Brief

A clinical study evaluating THRIVE Online PAT Program for Breast Cancer and DCIS. Completed, enrolled 39 participants across 1 site.

Detailed Summary

The purpose of this study is to pilot and refine an online behavioral intervention based on Positive Affect Training (PAT) that aims to increase positive emotional attitudes and decrease negative emotional attitudes toward endocrine therapy (ET, i.e., anti-hormonal medication) and to increase positive affect and decrease negative affect more generally, among post-treatment breast cancer survivors who are prescribed ET to prevent recurrence of breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, DCIS
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedApr 29, 2024
Enrollment StartMar 12, 2024
Primary CompletionApr 18, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.2 years ago

Interventions

THRIVE Online PAT Programbehavioral

Online program: behavioral intervention based on Positive Affect Training (PAT)